220 — Lewes, Delaware

220 is a clinical research site located in Lewes, Delaware, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

220 has participated in 1 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lewes

Browse all research sites in Delaware · View every site in Lewes

• Beebe Medical Center
• Tunnell Cancer Center at Beebe Medical Center
• Delaware Arthritis
• Research Site
• Investigational Site Number 840130
• Rheumatology Consultants of Delaware dba Delaware Arthritis
• Rheumatology Consultants of Delaware
• Rheumatolgy Consultants of Deleware
• 111
• Delaware Arthritis /ID# 142803
• 218
• Beebe Healthcare Tunnell Cancer Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 220?

220 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 220 conducted?

220 has 1 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 220 accredited by Crixeo Clinical Trials?

220 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 220?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.